• Ingen resultater fundet

KonformitätserklärungDeclaration of Conformity EffectiveEffective

N/A
N/A
Info
Hent
Protected

Academic year: 2023

Del "KonformitätserklärungDeclaration of Conformity EffectiveEffective"

Copied!
5
0
0

Indlæser.... (se fuldtekst nu)

Hele teksten

(1)

Konformitätserklärung Declaration of Conformity

Wir We

B. Braun Melsungen AG Carl-Braun-Straße 1

34212 Melsungen Deutschland/Germany erklären in eigener Verantwortung,

dass das/die Produkt/e

hereby declare in our own responsibility that the product/s

Ecoflac® Mix Ecoflac® Mix

Transferkappe für sterile Flüssigkeiten Transfer cap for sterile fluids

Ecoflac® Connect Ecoflac® Connect

Transferset, geschlossenes System Transfer set, closed system

Transofix® Transofix®

Überleitungsset Fluid transfer set

(Artikelnummern siehe Anlage I) (article numbers see attachment I) mit den Anforderungen der folgenden Richtlinie

übereinstimmt/übereinstimmen

is/are in compliance with the following directive

Richtlinie 93/42/EWG des Rates vom 14. Juni 1993

über Medizinprodukte

geändert durch Richtlinie 2007/47/EG

Council Directive 93/42/EEC of 14th June 1993

concerning Medical Devices amended by Directive 2007/47/EC Konformitätsbewertungsverfahren

nach Anhang VII und V der oben genannten Richtlinie

Conformity Assessment Procedure according to annex VII and V of the Council Directive named above Klassifizierung

gemäß Anhang IX der oben genannten Richtlinie

Classification according to annex IX of the Council Directive named above

Klasse I steril Class I sterile

Benannte Stelle Notified Body

TÜV SÜD Product Service GmbH Ridlerstraße 65

80339 München Deutschland Kennnummer 0123

TÜV SÜD Product Service GmbH Ridlerstraße 65

80339 München Germany

Identification number 0123 Datum der ersten CE-Kennzeichnung Date of first CE-marking

Ecoflac® Mix 2007-06

Transofix® 2007-06

Ecoflac® Connect 2009-06

Ecoflac® Mix 2007-06

Transofix® 2007-06

Ecoflac® Connect 2009-06

Document No.: 39.05.014 - Version: 20.0 - Document ID: RA-IVS 627 Print Date - Gedruckt am: 2021-05-14 13:05 (CET)

This document contains information that is the confidential and proprietary property of B. Braun. Any dissemination, distribution or copying of this document is strictly prohibited without the prior written consent of B. Braun. Anyone receiving this document in error should immediately notify B. Braun’s Legal Department and return this document to B. Braun Melsungen AG. Viewed by:IF-PIM-Admin

Effective

(2)

Gültig bis Valid until

2024-05-26 2024-05-26

Document No.: 39.05.014 - Version: 20.0 - Document ID: RA-IVS 627 Print Date - Gedruckt am: 2021-05-14 13:05 (CET)

- Conformity Declaration - Declaration of Conformity - 39.05.014 - Ecoflac Transofix

B. Braun Melsungen AG IV Systems - Regulatory Affairs Document No.: 39.05.014 Version: 20.0 Effective Date: 2019-06-21 Page: 2 of 5

Effective

Effective

(3)

Anlage I / Attachment I

Art.-Nr. / Art. No. Produktname / Product name Klasse / Class

16401 Ecoflac® Mix I steril / I sterile

16401IN Ecoflac® Mix I steril / I sterile

4090500 Transofix® I steril / I sterile

4090500IN Transofix® I steril / I sterile

4090549 Ecoflac® Connect I steril / I sterile

4090550 Ecoflac® Connect I steril / I sterile

4090552 Ecoflac® Connect I steril / I sterile

Document No.: 39.05.014 - Version: 20.0 - Document ID: RA-IVS 627 Print Date - Gedruckt am: 2021-05-14 13:05 (CET)

Effective

(4)

Amendment Information

Version Description of the changes

16 Delete out of market art. no. 0043066L, 0064500J, 0059572C, 0057124S, 15093, 3975002, 0005618G, 0005619H, 0005620J, 0065203Y

17 Add art. no. 4090500IN

18 Delete out of market art. no. 0043070R 19 Add art. no. 16401IN

20 Delete out of market art. no. 4089510, 0010724G, 0011243W, 0044834H

Document No.: 39.05.014 - Version: 20.0 - Document ID: RA-IVS 627 Print Date - Gedruckt am: 2021-05-14 13:05 (CET)

- Conformity Declaration - Declaration of Conformity - 39.05.014 - Ecoflac Transofix

B. Braun Melsungen AG IV Systems - Regulatory Affairs Document No.: 39.05.014 Version: 20.0 Effective Date: 2019-06-21 Page: 4 of 5

Effective

Effective

(5)

This document is signed electronically in compliance with the B. Braun electronic signature policies and procedures by following persons:

UserName: Herbst, Caroline (fuehcade) Title: Administrator Regulatory Affairs

Date: Monday, 17 June 2019, 15:33 W. Europe Daylight Time Meaning: Document signed as Author

================================================

UserName: Brand, Thomas (brantode)

Title: HC-QM-DE08 Vice President QM for non-active Medical Devices Date: Tuesday, 18 June 2019, 08:38 W. Europe Daylight Time

Meaning: Approve Document

================================================

UserName: Seidel, Stefan (seidstde)

Title: HC-RA-DE08E - Head of Regulatory Affairs CoE IV Systems Date: Friday, 21 June 2019, 10:34 W. Europe Daylight Time Meaning: Approve Document

================================================

Title: Declaration of Conformity - 39.05.014 - Ecoflac Transofix Initiator: Caroline ? Herbst

Document No.: 39.05.014 - Version: 20.0 - Document ID: RA-IVS 627 Print Date - Gedruckt am: 2021-05-14 13:05 (CET)

Effective

Referencer

RELATEREDE DOKUMENTER

Intrafix® SafeSet, Primeline, SafeSet 赛菲特 ® Infusionsgeräte mit Belüftung

TÜV SÜD Product Service GmbH Ridlerstraße 65.

TÜV SÜD Product Service GmbH Ridlerstraße 65. 80339 München Deutschland

nach Anhang II (ausgenommen Abschnitt 4) der oben genannten Richtlinie. Conformity Assessment Procedure according to annex II (excluding

Document No.: 39.05.016 - Version: 16.0 - Document ID: RA-IVS 630 Print Date - Gedruckt am: 2021-05-26 22:08 (CET). This document contains information that is

Document No.: 39.05.015 - Version: 16.0 - Document ID: RA-IVS 629 Print Date - Gedruckt am: 2021-05-26 22:08 (CET). This document contains information that is

Infusionsleitung PE, Infusions-Leitung PE, Original Perfusor®-Leitung, Original-Perfusor® Leitung PCA, Original Perfusor®-Leitung Typ: MR, Original Perfusor®-Leitung Typ:

nach Anhang II (ausgenommen Abschnitt 4) der oben genannten Richtlinie. Conformity Assessment Procedure according to annex II (excluding